Bretylium tosylate intravenous admixture compatibility. II: Dopamine, lidocaine, procainamide, and nitroglycerin. 1981

Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D001949 Bretylium Compounds Benzylammonium compounds with the formula Br-phenyl-CN+R3 that include BRETYLIUM TOSYLATE. Compounds, Bretylium
D001950 Bretylium Tosylate An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic. Bretylate,Bretylium Tosilate,Bretylol,Ornid
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004344 Drug Incompatibility The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed) Drug Incompatibilities,Incompatibilities, Drug,Incompatibility, Drug
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl

Related Publications

Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
June 1980, American journal of hospital pharmacy,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
December 1980, Annals of emergency medicine,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
November 1990, The American journal of emergency medicine,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
November 1971, American heart journal,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
June 1975, American journal of hospital pharmacy,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
May 1978, American journal of hospital pharmacy,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
September 1979, American journal of hospital pharmacy,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
June 1983, American journal of hospital pharmacy,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
July 1983, The American journal of emergency medicine,
Y C Lee, and A W Malick, and A H Amann, and D M Baaske, and J J Shah, and D M Wagenknecht, and J E Carter
July 1990, American journal of hospital pharmacy,
Copied contents to your clipboard!